期刊文献+

沙眼衣原体质粒蛋白pORF5原核表达及免疫原性鉴定 被引量:5

Expression and immunogenicity of the pORF5 plasmid protein from Chlamydia trachomatis
下载PDF
导出
摘要 目的构建沙眼衣原体(CT)pORF5蛋白基因重组质粒pGEX-6p/pORF5,表达并纯化质粒蛋白pORF5,并鉴定其免疫原性。方法用PCR法扩增pORF5基因,定向插入pGEX-6p原核表达载体构建原核表达重组体pGEX-6p/pORF5,重组体经酶切、PCR及测序鉴定后,经IPTG诱导在大肠杆菌中表达pORF5融合蛋白,融合蛋白纯化后免疫BALB/c鼠,ELISA及Western-blot分析pORF5质粒蛋白免疫原性及免疫反应性。结果PCR扩增出795 bp基因片段,序列测定证实重组质粒插入片段与GenBank登陆的D型Ct一致;pORF5融合蛋白在大肠杆菌中获得高效表达;ELISA检测免疫小鼠的血清效价为1∶25 600。结论pORF5蛋白在原核细胞中可有效表达并具有较好的免疫原性,为进一步研究该蛋白的结构功能、阐明Ct的致病机制、研制基因工程疫苗提供了有利的条件。 [ Objective ] To construct the recombinant plasmid containing pORF5 gene from Chlamydia trachomatis and study its immunogenicity in mice. [Methods] pORF5 gene was amplified from the genomie DNA of Ct serovar D by PCR and cloned into appropriate site of pGEX-6p vector to construct pGEX-6p/pORF5. After identification by PCR, restrictive enzymes digestion and sequencing, the recombinant plasmid was transformed into E.coli to express the fusion protein. The fusion protein was used to immunize BALB/c mice. ELISA and Western bolt were carried out to identify the immunogenicity and immunoreactivity. [Results] The pORF5 gene about 795bp was obtained. The DNA sequence of pORF5 gene was consistent with the published nucleotide sequence, pORF5 was suecessfully expressed as GST fusion proteins in E.coli. The ELISA result showed the specific antibody titer of pORF5 reached 1:25600. [Conclusion] pORF5 protein was successfully expressed in prokaryotic system and the specific anti-pORF5 antibody was induced in BALB/c mice, which lay a foundation for the further study on pORF5 protein function and vaccine development.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第4期517-520,共4页 China Journal of Modern Medicine
关键词 沙眼衣原体 pORF5基因 免疫原性 原核表达 chlamydia trachomatis pORF5 gene immunogenicity prokaryotic expression
  • 相关文献

参考文献7

  • 1KILMARX PH, MOCK PA, LEVINE WC. Effect of Chlamydia trachomatis co-infection on HIV shedding in genital tract secretions[J]. Sex Transm Dis, 2001, 28(6): 347-348.
  • 2SMITH JS, MU?OZ N, HERRERO R, et al. Evidence for Chlamydia trachomatis as a human papiUomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines [J]. J Infect Dis, 2002, 185(3): 324-331.
  • 3TAMIM H, FINAN RR, SHARIDA HE, et al. Cervicovaginal coinfections with human papiUomavirus and Chlamydia trachomatis[J]. Diagn Microbiol Infect Dis, 2002, 43(4): 277-281.
  • 4WALLIN KL, WIKLUND F, LUOSTARINEN T, et al. A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma[J]. Int J Cancer, 2002, 101(4): 371-374.
  • 5SHARMA J, ZHONG Y, DONG F, et al. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proreins[J]. Infect Immun, 2006, 74: 1490-1499.
  • 6O'CONNELL, CM INGALLS RR, ANDREWS CW, et al. Plasmid-deficient chlamydia muridarum fail to induce immune pathology and protect against oviduct disease [J]. The Journal of Immunology, 2007, 179(64): 4027-4034.
  • 7PICKETT MA,EVERSON JS, PEAD PJ, et al. The plasmids of Chlamydia trachomatis and Chlamydophila pneumoniae (N16): accurate determination of copy number and the paradoxical effect of plasmid--curing agents[J]. Microbiology, 2005, 151: 893-903.

同被引文献20

  • 1周洲,吴移谋,刘劼,陈超群,杨玲.肺炎衣原体ompA基因VD2-VD3区重组蛋白在血清学诊断中的初步应用[J].微生物学报,2007,47(3):512-516. 被引量:6
  • 2Murphey C,,Murthy AK,Meier PA,et al.The protective efficacy of chlamydial protease-like activity factor vaccina-tion is dependent upon CD4+T cells. Cellular Immunology . 2006
  • 3Wang J,Zhang Y,Lu C,et al.A genome-wide profiling ofthe humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans. J Immunol .
  • 4Starnbach MN,Roan NR.Conquering sexually transmitted diseases. Nature Reviews Immunology . 2008
  • 5Brunham R. C,Pourbohloul B,Mak S.et al.The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. Journal of Infection . 2005
  • 6Schachter,J.Overview of Chlamydia trachomatis infection and the requirements for a vaccine. Reviews of Infectious Diseases . 1985
  • 7Karunakaran,K.P,J Rey-Ladino,N.Stoynov,et al.Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia. J Immunol . 2008
  • 8Anttila T,Saikku P,Koskela P,et al.Serotypes of chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. Journal of the American Medical Association, The . 2001
  • 9李忠玉,汪世平,吴移谋,钟光明,陈玎.沙眼衣原体质粒蛋白pORF5核酸疫苗抗衣原体生殖道感染免疫保护作用[J].中国科学(C辑),2008,38(9):865-872. 被引量:2
  • 10唐国芳,李忠玉,吴移谋.γ干扰素抗衣原体感染作用的研究进展[J].微生物与感染,2009,4(2):103-107. 被引量:1

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部